Literature DB >> 3048761

A quantitative approach to recommendations on malaria prophylaxis.

M Pappaioanou, H O Lobel, C C Campbell.   

Abstract

In order to develop recommendations for malaria prophylaxis, a quantitative method is needed to balance the risk of Plasmodium falciparum malaria infections against the toxicity of antimalarial drugs. Using decision analysis, we estimated the expected mortality associated with three alternative regimens of prophylactic drugs for visitors to three areas with different risks of infection with chloroquine-resistant P. falciparum. The model used took into account the risks of malaria and of adverse reactions to antimalarial drugs. Estimates of the parameters used in the analysis were based on observations made on U.S. travellers. Reducing the risk of malaria infection was found to have a far greater impact on lowering the expected mortality than that of increasing the chemoprophylactic efficacy of the drugs used, thereby emphasizing the need for travellers to use anti-mosquito measures in malarious areas. The analytical method described can be used to define optimal malaria prevention strategies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048761      PMCID: PMC2491167     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Amodiaquine induced agranulocytosis and liver damage.

Authors:  K A Neftel; W Woodtly; M Schmid; P G Frick; J Fehr
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1985-04-12       Impact factor: 17.586

3.  Maloprim and agranulocytosis.

Authors:  L J Bruce-Chwatt; D B Hutchinson
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

4.  Fatal malaria in US civilians.

Authors:  H O Lobel; C C Campbell; J M Roberts
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

5.  Strategies for the prevention of malaria in travellers: comparison of drug regimens by means of risk-benefit analysis.

Authors:  T E Peto; C F Gilks
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

6.  Drug-resistant malaria--changing patterns mean difficult decisions.

Authors:  H C Spencer
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

7.  Recent trends in the importation of malaria caused by Plasmodium falciparum into the United States from Africa.

Authors:  H O Lobel; C C Campbell; I K Schwartz; J M Roberts
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

Authors:  C S Hatton; T E Peto; C Bunch; G Pasvol; S J Russell; C R Singer; G Edwards; P Winstanley
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

9.  In vivo efficacy of chloroquine treatment for Plasmodium falciparum in Malawian children under five years of age.

Authors:  C O Khoromana; C C Campbell; J J Wirima; D L Heymann
Journal:  Am J Trop Med Hyg       Date:  1986-05       Impact factor: 2.345

10.  Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.

Authors:  K D Miller; H O Lobel; R F Satriale; J N Kuritsky; R Stern; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1986-05       Impact factor: 2.345

View more
  1 in total

Review 1.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.